Recently, the WHO lymphoma classification was updated, and high-grade B-cell lymphoma with MYC and BCL2 gene rearrangements (HGBCL) was designated as its own subtype, with an inferior prognosis compared to DLBCL-NOS [5]. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.